Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
NCT Number: NCT01516333
The study is to examine the effect of four diets differing in glycemic index and amount of carbohydrate on blood sugar and insulin and in hunger, satiety, and vigor.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 1
Baton Rouge, Louisiana, 70808, United States
The extent to which a food raises blood sugar after its consumption is ranked using the Glycemic Index (GI). Foods with a high GI are those taht cause a large and rapid rise in blood sugar while those with a low GI produce small fluctuations in blood sugar. It is believed that low GI foods are advantageous for health since the swings in blood sugar and insulin resistant or diabetic. Interestingly, some studies suggest that low GI food make you less hungry and that this may play an important role in body weight regulation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Three meals a day
Three meals a day
Three meals a day
Three meals a day
Time frame: 1 month
Blood glucose demonstrates that diets of different glycemic load result in measurable differences in serum glucose and insulin.
Time frame: 1 month
Hunger, satiety, and vigor will be measured by the visual analog scales.
Pennington Biomedical Research Center
Other
Response of Energy Peak Levels After Carbohydrates Are Eaten Glycemic Load and Satiety Study - Phase 1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07427654
Callosities, Glycemic Index
Toronto, Ontario, Canada
View Trial DetailsNCT05903625
Glucose Metabolism Disorders, Glycemic Index
Lahore, Pakistan
View Trial DetailsNCT06152874
Glucose Metabolism Disorders, Glucose Response
Udine, Italy
View Trial DetailsNCT06288178
Blood Glucose, Body Weight
Trabzon, Turkey (Türkiye)
View Trial Details